Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.52 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.52 |
| ▸ | APP | P05067 | 3/20 | 0.50 |
| ▸ | KDM4A | O75164 | 2/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | INSR | P06213 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29860214 | 1.00 | CHRM2 (0.52) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL18796805 | 1.00 | CHRM2 (0.52) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL26962497 | 0.96 | KDM4A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL21545296 | 0.96 | KDM4A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29358876 | 0.96 | KDM4A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29859878 | 0.96 | KDM4A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL4298270 | 0.90 | CHRM2 (0.52) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL83585 | 0.90 | CHRM2 (0.52) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Water SCHEMBL22655271 | 0.89 | CHRM2 (0.51) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Water SCHEMBL22655270 | 0.89 | CHRM2 (0.51) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 754 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250052753-A1 | SINGLE PARTICLE ANALYSIS METHOD FOR VIRAL NUCLEIC ACID VECTOR | NANOFCM ASIA PTE.LTD. (SG) | 2025-02-13 | — | — | US | claimed |
| CN-117165721-A | Single particle analysis method of viral nucleic acid vector | 厦门福流生物科技有限公司 | 2023-12-05 | — | — | CN | claimed |
| WO-2023164252-A1 | ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-31 | — | — | WO | claimed |
| US-11486829-B2 | Optical analyses of particles and vesicles | SCINTILLON INSTITUTE FOR BIOMEDICAL AND BIOENERGY RESEARCH (US) | 2022-11-01 | — | — | US | claimed |
| US-11371085-B2 | Reagents and methods for isothermal chain reaction | MANCEBO RICARDO (US) | 2022-06-28 | — | — | US | claimed |
| US-20260146281-A1 | METHODS AND COMPOSITIONS FOR MULTIMODAL IN SITU ANALYSIS | 10X GENOMICS, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260139301-A1 | CATALYTIC DE-CROSSLINKING OF SAMPLES FOR IN SITU ANALYSIS | 10X GENOMICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| WO-2026107198-A1 | ANTIBODY BIOMARKER TO DIAGNOSE IDIOPATHIC INFLAMMATORY MYOPATHIES | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260139300-A1 | NUCLEIC ACID CONCATEMERS AND METHODS FOR STABILIZING AND/OR COMPACTING THE SAME | 10X GENOMICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260132451-A1 | RESOLVING SPATIAL ARRAYS BY PROXIMITY-BASED DECONVOLUTION | 10X GENOMICS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4739790-A1 | METHODS AND COMPOSITIONS FOR STABILIZING CONCATEMERS | Pacific Biosciences of California, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739352-A1 | HUMAN THERAPY UTILIZING NOVEL PROKARYOTIC VOLTAGE GATED SODIUM CHANNELS | Duke University (US) | 2026-05-13 | — | — | EP | disclosed |
| WO-2021263211-A9 | ANTIGEN-SPECIFIC T CELL RECEPTORS AND CHIMERIC ANTIGEN RECEPTORS, AND METHODS OF USE IN IMMUNE SIGNALING MODULATION FOR CANCER IMMUNOTHERAPY | Houston Methodist Hospital (US) | 2022-02-03 | — | — | WO | disclosed |
| US-20220033888-A1 | GENERATING CAPTURE PROBES FOR SPATIAL ANALYSIS | 10X GENOMICS, INC. (US) | 2022-02-03 | — | — | US | disclosed |
| US-20220031848-A1 | BIOINK FOR 3D DEPOSITION | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2022-02-03 | — | — | US | disclosed |
| US-11236149-B2 | Microbe-binding molecules and uses thereof | PRESIDENT AND FALLOWS OF HARVARD COLLEGE (US) | 2022-02-01 | — | — | US | disclosed |
| US-20220025446-A1 | METHODS OF USING MASTER / COPY ARRAYS FOR SPATIAL DETECTION | 10X GENOMICS, INC. (US) | 2022-01-27 | — | — | US | disclosed |
| US-20220026364-A1 | SYSTEMS AND METHODS FOR DETECTION | LUMENCOR, INC. | 2022-01-27 | — | — | US | disclosed |
| EP-3941630-A1 | PRECISE DELIVERY OF COMPONENTS INTO FLUIDS | Cellular Research, Inc. (US) | 2022-01-26 | — | — | EP | disclosed |
| WO-2017073728-A1 | ULTRATHIN FILM PHOTOLUMINESCENCE SENSOR | 学校法人早稲田大学 | 2017-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139300-A1 | NUCLEIC ACID CONCATEMERS AND METHODS FOR STABILIZING AND/OR COMPACTING THE SAME | INCENP, SLIRP, SMCHD1 | CHRM2 4878/4885CHRM4 4738/4885CHRM5 4864/4885 |
| US-20260146281-A1 | METHODS AND COMPOSITIONS FOR MULTIMODAL IN SITU ANALYSIS | BRCA1, MKI67, STAT3 | CHRM2 3851/4885CHRM4 2750/4885CHRM5 4029/4885 |
| US-20260139301-A1 | CATALYTIC DE-CROSSLINKING OF SAMPLES FOR IN SITU ANALYSIS | RNGTT, NSUN2, POLL | CHRM2 3534/4885CHRM4 1866/4885CHRM5 2379/4885 |
| US-20260132451-A1 | RESOLVING SPATIAL ARRAYS BY PROXIMITY-BASED DECONVOLUTION | RNGTT, ADAR, CPSF1 | CHRM2 4537/4885CHRM4 3862/4885CHRM5 4696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.